Patent Published 2019

N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONS - PV 2019-757 (Voller) KINETIN

Cite
  • 2019 Year

Description

  1. Patent: CZ 310035. Granted: 18.4.2024. Ownership: Palacký University Olomouc; Institute of Physiology CAS. Inventors: VOLLER Jiří, SLÁDEK Martin, HAJDÚCH Marián, SUMOVÁ Alena, STRNAD Miroslav
  2. Published Application PCT/CZ2020/050094 under WO 2021/115502 (17.6.2021)
  3. Patent: US 12,558,358. Granted: 24.2.2026. Ownership: Palacký University Olomouc; Institute of Physiology CAS. Inventors: VOLLER Jiří, SLÁDEK Martin, HAJDÚCH Marián, SUMOVÁ Alena, STRNAD Miroslav
  4. Patent: EP 4072555. Granted: 22.1.2025. Ownership: Palacký University Olomouc; Institute of Physiology CAS. Inventors: VOLLER Jiří, SLÁDEK Martin, HAJDÚCH Marián, SUMOVÁ Alena, STRNAD Miroslav

Status: Available

Cite this publication

N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONS - PV 2019-757 (Voller) KINETIN Patent: CZ 310035. Granted: 18.4.2024. Ownership: Palacký University Olomouc; Institute of Physiology CAS. Inventors: VOLLER Jiří, SLÁDEK Martin, HAJDÚCH Marián, SUMOVÁ Alena, STRNAD Miroslav Published Application PCT/CZ2020/050094 under WO 2021/115502 (17.6.2021) Patent: US 12,558,358. Granted: 24.2.2026. Ownership: Palacký University Olomouc; Institute of Physiology CAS. Inventors: VOLLER Jiří, SLÁDEK Martin, HAJDÚCH Marián, SUMOVÁ Alena, STRNAD Miroslav Patent: EP 4072555. Granted: 22.1.2025. Ownership: Palacký University Olomouc; Institute of Physiology CAS. Inventors: VOLLER Jiří, SLÁDEK Martin, HAJDÚCH Marián, SUMOVÁ Alena, STRNAD Miroslav Status: Available.

Details

Priority application
PV 2019-757
Date of filing
8. 12. 2019

WHERE TO FIND US

Hněvotínská 1333/5
779 00 Olomouc
Czech Republic

+420 585632111
+420 585632180
recepce.umtm@upol.cz
info@imtm.cz

GPS: 49° 35´ 10.1869512" N, 17° 14´ 6.292305" E

ABOUT IMTM

Our mission is to perform basic and translational biomedical research with an aim to better understand the underlying cause of human infectious diseases and cancer, and to develop future human medicines, medical devices and diagnostics. Our vision is to facilitate private-public partnership and research collaboration, and to integrate member researchers into international platforms. LEARN MORE ABOUT IMTM

HELPDESK PORTAL
© 2026 Institute of Molecular and Translational Medicine

This website uses cookies

We use necessary cookies to make the website work. With your consent we also use analytics cookies and show embedded content from other services that may set their own cookies. You can change your choice at any time under "Cookie settings" at the bottom of every page. Privacy policy

Cookie settings

Choose which cookies we may use. Your choice is stored for 6 months. Privacy policy

  • Required for the website to work – e.g. your session when logged in, security and remembering this choice. They cannot be switched off.

  • Help us understand how visitors use the website so we can improve it (Google Analytics, anonymised IP address).

  • Show content embedded from YouTube, X (Twitter), Facebook, Google Maps and Czech Radio. These services may set their own cookies.